We are live on
!
Find out more
KB
Kimelman & Baird Portfolio holdings
AUM
$1.36B
1-Year Est. Return
26.27%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+26.27%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$532M
AUM Growth
–
Cap. Flow
+$532M
Cap. Flow
% of AUM
100.12%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$27.6M |
| 2 |
GE Aerospace
GE
|
+$25.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$25.6M |
| 4 |
Copart
CPRT
|
+$24.1M |
| 5 |
CMD
Cantel Medical Corporation
CMD
|
+$24M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.32% |
| 2 | Healthcare | 16.89% |
| 3 | Consumer Discretionary | 12.15% |
| 4 | Communication Services | 11.59% |
| 5 | Financials | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Walmart Inc
WMT
$850B
| $464K | 0.09% |
+22,710
| New | +$456K |
|
|
PSIX
77
Power Solutions International
PSIX
$934M
| $450K | 0.08% |
+24,682
| New | +$532K |
|
78
TechnipFMC
FTI
$31.3B
| $435K | 0.08% |
+20,160
| New | +$487K |
|
79
Philip Morris
PM
$284B
| $422K | 0.08% |
+4,795
| New | +$416K |
|
80
FMC
FMC
$1.62B
| $391K | 0.07% |
+11,530
| New | +$395K |
|
81
Coca-Cola
KO
$379B
| $369K | 0.07% |
+8,600
| New | +$365K |
|
82
Timken Company
TKR
$8.53B
| $366K | 0.07% |
+12,800
| New | +$385K |
|
83
Dominion Energy
D
$57.9B
| $358K | 0.07% |
+5,300
| New | +$366K |
|
84
ConocoPhillips
COP
$161B
| $343K | 0.06% |
+7,350
| New | +$384K |
|
85
Biogen
BIIB
$32.6B
| $306K | 0.06% |
+1,000
| New | +$287K |
|
|
ISEE
86
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $287K | 0.05% |
+3,650
| New | +$211K |
|
87
Zimmer Biomet
ZBH
$18.7B
| $276K | 0.05% |
+2,772
| New | +$271K |
|
88
Altria Group
MO
$115B
| $271K | 0.05% |
+4,655
| New | +$270K |
|
|
AGN
89
DELISTED
Allergan plc
AGN
| $257K | 0.05% |
+821
| New | +$244K |
|
90
Gilead Sciences
GILD
$187B
| $255K | 0.05% |
+2,517
| New | +$262K |
|
91
LCNB Corp
LCNB
$278M
| $245K | 0.05% |
+15,000
| New | +$242K |
|
|
PX
92
DELISTED
Praxair Inc
PX
| $244K | 0.05% |
+2,380
| New | +$260K |
|
|
CB
93
DELISTED
CHUBB CORPORATION
CB
| $239K | 0.04% |
+1,800
| New | +$233K |
|
94
Deere & Co
DE
$187B
| $229K | 0.04% |
+3,000
| New | +$232K |
|
95
Ventas
VTR
$46.3B
| $222K | 0.04% |
+3,933
| New | +$214K |
|
96
Pfizer
PFE
$162B
| $218K | 0.04% |
+7,113
| New | +$224K |
|
97
Southern Company
SO
$101B
| $206K | 0.04% |
+4,410
| New | +$200K |
|
98
Enterprise Products Partners
EPD
$84.1B
| $205K | 0.04% |
+8,000
| New | +$208K |
|
99
Mondelez International
MDLZ
$78.2B
| $201K | 0.04% |
+4,482
| New | +$200K |
|
|
ESSX
100
DELISTED
ESSEX RENTAL CORP. COMMON STOCK
ESSX
| $103K | 0.02% |
+633,806
| New | +$169K |
|
Similar funds
RCYC
PP
HVCM
NOSC
TF
GGS
IB
BSB
Kimelman & Baird's Q4 2015 Portfolio in Review
As of Q4 2015, Kimelman & Baird held 108 positions worth $532M. Its ten largest holdings account for 41% of the portfolio.
Kimelman & Baird deployed $532M of net new capital in Q4 2015, opening 108 new positions. Its largest new stake was ExxonMobil: 344,659 shares worth $26.9M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, followed by Healthcare and Consumer Discretionary.
- Kimelman & Baird's largest Q4 2015 buy was ExxonMobil: 344,659 shares worth $26.9M.
- Kimelman & Baird's ten largest holdings make up 41% of its $532M portfolio in Q4 2015.
- Kimelman & Baird opened 108 new positions and closed 0 in Q4 2015.
Based on Kimelman & Baird's 13F filing for Q4 2015, filed 12 Feb 2016.